| Code | Description | Claims | Beneficiaries | Total Paid |
| 83970 |
|
95,361 |
86,930 |
$2.82M |
| 82728 |
|
68,936 |
62,098 |
$664K |
| 84460 |
|
221,281 |
208,550 |
$535K |
| 83550 |
|
87,883 |
79,764 |
$525K |
| 83540 |
|
89,381 |
81,136 |
$427K |
| 86803 |
|
36,466 |
35,018 |
$371K |
| 83615 |
|
68,899 |
64,214 |
$328K |
| 82310 |
|
72,384 |
54,098 |
$310K |
| 84100 |
|
80,484 |
56,503 |
$306K |
| 84450 |
|
69,814 |
64,794 |
$274K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
50,377 |
47,429 |
$255K |
| 87340 |
|
32,614 |
29,698 |
$210K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
9,005 |
8,259 |
$194K |
| 82108 |
|
12,307 |
11,256 |
$180K |
| 80061 |
Lipid panel |
15,086 |
14,206 |
$119K |
| 84295 |
|
48,366 |
43,127 |
$112K |
| 84132 |
|
30,307 |
15,835 |
$105K |
| 86706 |
|
13,238 |
12,214 |
$94K |
| 85018 |
|
30,357 |
19,423 |
$62K |
| 84520 |
|
22,303 |
10,652 |
$57K |
| 86704 |
|
6,160 |
5,745 |
$57K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,294 |
1,127 |
$47K |
| 87522 |
Neg quan hep c or qual rna |
1,647 |
1,514 |
$41K |
| 87040 |
|
4,476 |
2,366 |
$35K |
| 80051 |
|
6,594 |
3,130 |
$34K |
| 82746 |
|
2,388 |
2,202 |
$27K |
| 82565 |
|
6,779 |
2,864 |
$26K |
| 84466 |
|
1,987 |
1,894 |
$23K |
| 82570 |
|
6,684 |
3,728 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,327 |
2,168 |
$22K |
| 83718 |
|
2,907 |
2,784 |
$21K |
| 83735 |
|
5,512 |
4,879 |
$21K |
| 82040 |
|
5,701 |
3,963 |
$18K |
| 85045 |
|
5,895 |
4,993 |
$16K |
| 82607 |
|
1,393 |
1,287 |
$16K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,396 |
2,165 |
$14K |
| 84540 |
|
2,603 |
2,176 |
$8K |
| 84075 |
|
2,176 |
1,988 |
$8K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
624 |
575 |
$8K |
| 80202 |
|
642 |
334 |
$7K |
| 84155 |
|
2,251 |
2,051 |
$6K |
| 87070 |
|
933 |
819 |
$6K |
| 87186 |
|
1,009 |
792 |
$6K |
| 85610 |
|
1,650 |
568 |
$4K |
| 82247 |
|
1,013 |
882 |
$4K |
| 87077 |
|
513 |
397 |
$3K |
| 82435 |
|
973 |
774 |
$2K |
| 82374 |
|
988 |
785 |
$2K |
| 84550 |
|
589 |
562 |
$2K |
| 82465 |
|
574 |
552 |
$2K |
| 82947 |
|
500 |
483 |
$2K |
| 82248 |
|
369 |
331 |
$2K |
| 87205 |
|
485 |
403 |
$2K |
| 82945 |
|
641 |
178 |
$2K |
| 84478 |
|
434 |
421 |
$1K |
| 85014 |
|
824 |
376 |
$1K |
| 87147 |
|
339 |
255 |
$1K |
| 89051 |
|
340 |
259 |
$1K |
| 84439 |
|
29 |
26 |
$209.58 |
| 85049 |
|
103 |
73 |
$197.00 |
| 84436 |
|
35 |
30 |
$111.16 |
| 85041 |
|
53 |
34 |
$29.31 |
| 85048 |
|
54 |
35 |
$27.55 |
| 99080 |
|
397 |
102 |
$0.00 |